Skip to main content
Translational Cancer Research logoLink to Translational Cancer Research
. 2020 Nov;9(11):7379–7380. doi: 10.21037/tcr-2020-005

Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity

Hongye Zhang 1, Ling Wang 2, Juan Bai 3, Wenyu Jiao 4, Mingxia Wang 1,
PMCID: PMC8797910  PMID: 35129549

MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity

In the January 2020 issue of Transl Cancer Res, the paper “MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity” by Dr. Zhang et al. (1) was published with an error in the Figure 3 by attaching a wrong Figure 3B.

The Figure 3B should be replaced and corrected as the below one.

graphic file with name tcr-09-11-7379-fig1.jpg

The authors regret the error and all inconveniences caused.

References

  • 1.Zhang H, Wang L, Bai J, et al. MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity. Transl Cancer Res 2020;9:346-57. 10.21037/tcr.2020.01.07 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Translational Cancer Research are provided here courtesy of AME Publications

RESOURCES